motor control assessment for Parkinson's (NCT04616508)
Understand and improve reaching corrections
- Trial ID
- NCT04616508
- Official Title
- Online Motor Control in People With Parkinson's Disease
- Goal
- Understand and improve reaching corrections
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Delaware
- Study Type
- INTERVENTIONAL
- Enrollment
- 100 participants
- Conditions
- Motor Control, Parkinson Disease
- Interventions
- motor control assessment
Summary For Families
The goal is to learn how people with Parkinson's adjust reaching movements when the environment suddenly changes, like when a target moves or when a force knocks the arm, and whether they handle small and large changes differently. Participants reach inside a virtual reality setup while the researchers apply visual changes or physical pushes to the arm at different strengths, and the study compares responses of people with Parkinson's to similar people without Parkinson's to help guide better rehabilitation. The study seeks adults 18 to 85 who can reach about 8 inches, score at least 26 on a brief thinking test, can attend all sessions, and for the Parkinson's group report an idiopathic diagnosis and be taking dopamine-related medication; people with other neurological disorders or arm injuries that affect reaching are excluded.
Locations
- University of Delaware, Newark, Delaware, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying motor control assessment. The goal is to learn how people with Parkinson's adjust reaching movements when the environment suddenly changes, like when a target moves or when a force knocks the arm, and whether they handle small and large changes differently. Participants reach inside a virtual reality setup while the researchers apply visual changes or physical pushes to the arm at different strengths, and the study compares responses of people with Parkinson's to similar people without Parkinson's to help guide better rehabilitation. The study seeks adults 18 to 85 who can reach about 8 inches, score at least 26 on a brief thinking test, can attend all sessions, and for the Parkinson's group report an idiopathic diagnosis and be taking dopamine-related medication; people with other neurological disorders or arm injuries that affect reaching are excluded.
- Who can participate?
- Participants must be between 18 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 6 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- Everyone in this trial receives the experimental treatment. There is no placebo group.